| MicroRNA in disease regulation | Lifetime | 340 | CN 122 | 98.77 |
| Circular RNAs in diseases | Lifetime | 197 | CN 109 | 98.51 |
| Cancer-related molecular mechanisms research | Lifetime | 524 | CN 236 | 98.41 |
| Ferroptosis and cancer prognosis | Lifetime | 741 | CN 427 | 93.60 |
| Flavonoids in Medical Research | Lifetime | 326 | CN 133 | 87.06 |
| Leech Biology and Applications | Lifetime | 357 | CN 5 | 72.32 |
| Bioactive Compounds in Plants | Lifetime | 443 | CN 108 | 57.90 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 86 | CN 36 | 97.15 |
| Microbial infections and disease research | 2021-2025 | 28 | CN 3 | 96.55 |
| MicroRNA in disease regulation | 2021-2025 | 168 | CN 110 | 97.64 |
| Cancer-related molecular mechanisms research | 2021-2025 | 296 | CN 227 | 97.52 |
| Circular RNAs in diseases | 2021-2025 | 113 | CN 81 | 97.18 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 207 | CN 63 | 93.93 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 136 | CN 81 | 93.43 |
| Diet and metabolism studies | 2021-2025 | 648 | CN 78 | 94.28 |
| RNA modifications and cancer | 2021-2025 | 948 | CN 646 | 93.67 |
| Immune cells in cancer | 2021-2025 | 454 | CN 249 | 92.53 |
| Gestational Diabetes Research and Management | 2021-2025 | 318 | CN 39 | 92.09 |
| Pregnancy and preeclampsia studies | 2021-2025 | 583 | CN 84 | 92.79 |
| Autophagy in Disease and Therapy | 2021-2025 | 409 | CN 202 | 89.63 |
| Cancer-related gene regulation | 2021-2025 | 345 | CN 232 | 87.79 |
| Heavy Metal Exposure and Toxicity | 2021-2025 | 335 | CN 132 | 90.14 |
| Trace Elements in Health | 2021-2025 | 354 | CN 129 | 85.63 |
| Traditional Chinese Medicine Analysis | 2021-2025 | 230 | CN 210 | 83.75 |
| Medical Imaging and Analysis | 2021-2025 | 509 | CN 144 | 84.19 |
| Phagocytosis and Immune Regulation | 2021-2025 | 298 | CN 117 | 79.86 |
| Bariatric Surgery and Outcomes | 2021-2025 | 797 | CN 25 | 83.19 |
| Cancer-related Molecular Pathways | 2021-2025 | 733 | CN 151 | 75.45 |
| Congenital heart defects research | 2021-2025 | 727 | CN 109 | 74.81 |
| Arsenic contamination and mitigation | 2021-2025 | 835 | CN 517 | 76.85 |
| Phytochemicals and Medicinal Plants | 2021-2025 | 400 | CN 23 | 73.84 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 948 | CN 377 | 72.11 |
| Bioactive Compounds in Plants | 2021-2025 | 41 | CN 24 | 72.79 |
| Composting and Vermicomposting Techniques | 2021-2025 | 489 | CN 305 | 72.56 |
| Flavonoids in Medical Research | 2021-2025 | 163 | CN 59 | 66.41 |
| Rabies epidemiology and control | 2021-2025 | 761 | CN 50 | 67.11 |
| Acupuncture Treatment Research Studies | 2021-2025 | 904 | CN 607 | 67.24 |
| Renal function and acid-base balance | 2021-2025 | 561 | CN 49 | 60.75 |
| Mine drainage and remediation techniques | 2021-2025 | 947 | CN 460 | 61.94 |
| Moyamoya disease diagnosis and treatment | 2021-2025 | 978 | CN 315 | 55.18 |
| Kruppel-like factors research | 2021-2025 | 788 | CN 316 | 50.88 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 942 | CN 112 | 35.95 |
| Origins and Evolution of Life | 2021-2025 | 790 | CN 69 | 19.83 |
